FindTrial
Sign In

To evaluate the correlation between serum zinc level with CD4 count before and after zinc supplemention.

zinc level in hiv infected patients and its correlation with CD4 count before and after zinc supplementation.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/11/038057
Enrollment
54
Registered
2021-11-15
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B20- Human immunodeficiency virus [HIV]disease

Interventions

Intervention1: Zinc tablet: Zinc 12mg/day for female Zinc 15mg/day for male For 3months Control Intervention1: not applicable: not applicable

Sponsors

Amit Das
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: HIV positive patients who are willing to participate

Exclusion criteria

Exclusion criteria: 1.terminally ill patients 2.Any co-morbid conditions(sepsis, renal impairment, liver impairment, malignancy or under chemotherapy. 3.pregnancy 4.HIV positive patients already on zinc supplementation.

Design outcomes

Secondary

MeasureTime frame
serum zinc level after 3months and its correlation with CD4 count.Timepoint: 3 months—

Primary

MeasureTime frame
serum zinc level in hiv patients at baseline.Timepoint: 3 months—

Countries

India

Contacts

Public ContactDrTh Brojendro singh

Regional institute of medical sciences

brojendroth@gmail.com7628896459

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026